LEADER 03804nam 2200505 450 001 9910814648503321 005 20230809224927.0 010 $a0-309-45135-3 010 $a0-309-45133-7 035 $a(CKB)3710000001417619 035 $a(MiAaPQ)EBC4895145 035 $a(EXLCZ)993710000001417619 100 $a20170726h20172017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aImplementation of lung cancer screening $eproceedings of a workshop /$fErin Balogh, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine 210 1$aWashington, District of Columbia :$cThe National Academies Press,$d2017. 210 4$dİ2017 215 $a1 online resource (129 pages) $cillustrations 311 $a0-309-45132-9 320 $aIncludes bibliographical references. 327 $aEvidence base for lung cancer screening -- Eligibility, clinical practice guidelines, and modeling -- Insurance coverage of lung cancer screening -- Shared decision making -- Challenges to implementation of lung cancer -- Screening programs -- Overcoming implementation challenges -- Screening program capacity -- Structuring lung cancer screening programs -- Ensuring the quality of lung cancer screening -- Smoking cessation and lung cancer screening -- Value and efficiency in lung cancer screening -- Suggested areas of research -- Workshop wrap-up. 330 1 $a"The public health burden from lung cancer is substantial: it is the second most commonly diagnosed cancer and the leading cause of cancer-related deaths in the United States. Given the individual and population health burden of lung cancer, especially when it is diagnosed at later stages, there has been a push to develop and implement screening strategies for early detection. However, many factors need to be considered for broad implementation of lung cancer screening in clinical practice. Effective implementation will entail understanding the balance of potential benefits and harms of lung cancer screening, defining and reaching eligible populations, addressing health disparities, and many more considerations. In recognition of the substantial challenges to developing effective lung cancer screening programs in clinical practice, the National Academies of Sciences, Engineering, and Medicine held a workshop in June 2016. At the workshop, experts described the current evidence base for lung cancer screening, the current challenges of implementation, and opportunities to overcome them. Workshop participants also explored capacity and access issues; best practices for screening programs; assessment of patient outcomes, quality, and value in lung cancer screening; and research needs that could improve implementation efforts. This publication summarizes the presentations and discussions from the workshop"--$cPublisher's description 606 $aLungs$xCancer$xTreatment$vCongresses 615 0$aLungs$xCancer$xTreatment 676 $a616.99424 700 $aBalogh$b Erin$01089066 702 $aBalogh$b Erin 702 $aPatlak$b Margie 702 $aNass$b Sharyl J. 712 02$aNational Cancer Policy Forum. 712 02$aBoard on Health Care Services. 712 02$aHealth and Medicine Division. 712 02$aNational Academies of Sciences, Engineering, Medicine. 712 12$aImplementation of Lung Cancer Screening (Workshop)$f(2016 :$eWashington, D.C.), 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910814648503321 996 $aImplementation of lung cancer screening$94015226 997 $aUNINA